US

New Business

Chinese AI start-up MiniMax shines on Hong Kong IPO debut

Shares of Chinese artificial intelligence start-up MiniMax Group surged on their Hong Kong debut on Friday, reflecting investor confidence after…

Read More »
New Business

US Senate to vote on curbing Trump’s military authority on Venezuela

Republicans blocked measures, but last vote was 49-51 as two GOP senators backed Democrats A photograph posted by US President…

Read More »
New Business

China says US trade war, tech curbs have spurred ‘independent innovation’

China’s economy has successfully weathered mounting shocks, including US tariffs and technology curbs, and continues to innovate despite a challenging…

Read More »
New Business

China’s massive oil-for-loan debts at risk in post-Maduro Venezuela: analysts

The US takeover of Venezuela has placed billions of dollars in Chinese oil-for-loan debts at risk, analysts say, though they…

Read More »
New Business

China stocks to see 20% upside on AI boom, global expansion: Goldman Sachs

China stocks are forecast to continue expanding in 2026, as equity gains are set to be driven more by earnings…

Read More »
New Business

UK unveils decade-long growth vision to Hong Kong investors

[The content of this article has been produced by our advertising partner.] The UK set out its growth agenda in…

Read More »
New Business

What assets does China have in Venezuela, and what could happen with Maduro gone?

Amid prolonged international sanctions imposed on Venezuela, Chinese enterprises stand out as some of the few willing to pour resources…

Read More »
New Business

Insilico signs US$888 million AI drug-development deal days after Hong Kong IPO

The deal comes just days after the US company’s shares debuted following its initial public offering (IPO), which raised HK$2.28…

Read More »
New Business

After Trump’s Venezuela takeover, China’s investors prep for Latin American era of anxiety

Chinese companies operating in Latin America are bracing for greater uncertainty rather than abrupt rupture, as Washington moves to reassert…

Read More »
New Business

The ‘biology winter’ thaws: why investors are piling into Hong Kong’s biotech IPOs

Hong Kong’s biotech fundraising momentum is expected to extend into 2026, as licensing deals and strong post-initial public offering (IPO)…

Read More »
Back to top button